P. Massari - Concepedia

Author

P. Massari

Also Known As

M Premont, P Massari, P U Massari, P. Massari, P. U. Massari, P.U. Massari, Pablo Massari, Pablo U Massari, Pablo U. Massari, Pablo Ulises Massari

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Hospital Privado Universidad Católica de Córdoba Bellvitge University Hospital University of California, San Francisco Bristol-Myers Squibb (United States)

About

P. Massari is an author at Hospital Privado specializing in medicine, nephrology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1.3K
2	Cell Biology	2	2	97
3	Health Sciences	1	1	15
4	Public Health	1	1	26
5	Social Sciences	1	1	16

P. Massari

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study) Flavio Vincenti, B Charpentier, Yves Vanrenterghem, American Journal of Transplantation Transplant RejectionUrologyTransplantationKidney TransplantMedicine	2010	931
Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients Flavio Vincenti, Christian P. Larsen, Josefina Alberú, American Journal of Transplantation	2011	308
Three-Year Outcomes From BENEFIT-EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys José Osmar Medina Pestana, J.M. Grinyó, Yves Vanrenterghem, American Journal of Transplantation	2012	259
Switching from Calcineurin Inhibitor-based Regimens to a Belatacept-based Regimen in Renal Transplant Recipients Lionel Rostaing, P. Massari, Valter Duro Garcı́a, Clinical Journal of the American Society of Nephrology	2010	183
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study Stefan P. Berger, Claudia Sommerer, Oliver Witzke, American Journal of Transplantation	2019	145
The fate of tritium labeled GM1 ganglioside injected in mice Paolo Orlando, G Cocciante, Giulio Ippolito, Pharmacological Research Communications GliomaGm1 GangliosideImmunologyToxicologyGlucocorticoid	1979	79
Safety Assessment of the Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Stable Renal Transplant Recipients P. Massari, Valter Duro‐Garcia, Fernando Girón, Transplantation Proceedings UrologyTransplantationEnteric-coated Mycophenolate SodiumKidney TransplantKidney Transplantation	2005	45
CKD-EPI Instead of MDRD for Candidates to Kidney Donation Pablo Luján, Carlos Chiurchiu, Walter Douthat, Transplantation	2012	41
Results of the Conversion to Everolimus in Renal Transplant Recipients With Posttransplantation Malignancies Carlos Chiurchiu, Cristian Alonso Duarte Carreño, Rubén Schiavelli, Transplantation Proceedings Posttransplantation MalignanciesUrologyTransplantationKidney TransplantMedicine	2010	38
Familial Hyperuricemia and Renal Disease P. Massari Archives of Internal Medicine	1980	35

Page 1